文献速递神经肿瘤

胶质瘤负荷自动评估:深度学习算法实现全自动体积与双径线测量

Automatic assessment of glioma burden: a deep learning algorithm for fully automated volumetric and bidimensional measurement.
PubMed 文献 · Neuro Oncol · 2019-01-01

本研究开发深度学习算法,自动分割FLAIR高信号和对比增强肿瘤,按RANO标准计算肿瘤体积和双径线乘积(AutoRANO)。在843例术前和54例术后纵向MRI中验证,自动与手动测量体积一致性高(ICC 0.915–0.965),双基线重复性ICC 0.977–0.991,显示在复杂治疗后评估肿瘤负荷的潜力。

要点

  • 深度学习算法可自动分割FLAIR高信号和对比增强肿瘤并计算AutoRANO。
  • 自动与手动测量体积一致性高,ICC 0.915–0.965。
  • 双基线重复性ICC 0.977–0.991,但需多中心临床试验验证。

核心结论

  • 自动算法在复杂治疗后评估肿瘤负荷有潜在应用价值,但广泛实施前需多中心临床试验验证。

研究设计与样本

  • 研究使用两个队列:843例来自4个机构的低级别或高级别胶质瘤患者术前MRI,以及来自1个机构的54例新诊断胶质母细胞瘤患者的713次术后纵向MRI随访(每例有2次治疗前基线MRI)。

主要发现

  • 在术后胶质母细胞瘤患者队列中,自动生成的FLAIR高信号体积、对比增强肿瘤体积和AutoRANO在双基线访视间的重复性高,组内相关系数(ICC)分别为0.986、0.991和0.977。
  • 手动与自动测量的肿瘤体积一致性高,术前FLAIR高信号、术后FLAIR高信号和术后对比增强肿瘤体积的ICC分别为0.915、0.924和0.965。
  • 手动与自动导出的肿瘤负荷纵向变化ICC分别为:FLAIR高信号体积0.917、对比增强肿瘤体积0.966、RANO测量0.850。

临床怎么用

  • 该算法可用于自动量化胶质瘤MRI上的FLAIR高信号和对比增强肿瘤体积及RANO双径线乘积,辅助治疗反应评估。

局限性

  • 广泛实施前需在多中心临床试验中进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Longitudinal measurement of glioma burden with MRI is the basis for treatment response assessment. In this study, we developed a deep learning algorithm that automatically segments abnormal fluid attenuated inversion recovery (FLAIR) hyperintensity and contrast-enhancing tumor, quantitating tumor volumes as well as the product of maximum bidimensional diameters according to the Response Assessment in Neuro-Oncology (RANO) criteria (AutoRANO). METHODS: Two cohorts of patients were used for this study. One consisted of 843 preoperative MRIs from 843 patients with low- or high-grade gliomas from 4 institutions and the second consisted of 713 longitudinal postoperative MRI visits from 54 patients with newly diagnosed glioblastomas (each with 2 pretreatment "baseline" MRIs) from 1 institution. RESULTS: The automatically generated FLAIR hyperintensity volume, contrast-enhancing tumor volume, and AutoRANO were highly repeatable for the double-baseline visits, with an intraclass correlation coefficient (ICC) of 0.986, 0.991, and 0.977, respectively, on the cohort of postoperative GBM patients. Furthermore, there was high agreement between manually and automatically measured tumor volumes, with ICC values of 0.915, 0.924, and 0.965 for preoperative FLAIR hyperintensity, postoperative FLAIR hyperintensity, and postoperative contrast-enhancing tumor volumes, respectively. Lastly, the ICCs for comparing manually and automatically derived longitudinal changes in tumor burden were 0.917, 0.966, and 0.850 for FLAIR hyperintensity volume, contrast-enhancing tumor volume, and RANO measures, respectively. CONCLUSIONS: Our automated algorithm demonstrates potential utility for evaluating tumor burden in complex posttreatment settings, although further validation in multicenter clinical trials will be needed prior to widespread implementation.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Chang K, Beers AL, Bai HX, et al. Automatic assessment of glioma burden: a deep learning algorithm for fully automated volumetric and bidimensional measurement. Neuro Oncol. 2019. PMID: 31190077. doi:10.1093/neuonc/noz106

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。